Table 1.
Dysport (€) 500 U vial | Botox (€) 100 U vial | |
---|---|---|
Europe | ||
Belgium (ex-factory price) | 222 | 167 |
Estonia (ex-factory price) | 274 | 157 |
France (ex-factory price) | 259 | 216 |
Germany (ex-factory price) | 410 | 332 |
Greece (ex-factory price) | 285 | 227 |
Hungary (ex-factory price) | 259 | 241 |
Italy (ex-factory price) | 175 | 129 |
Netherlands (pharmacist purchase price) | 272 | 225 |
Poland (ex-factory price) | 165 | 165 |
Portugal (ex-factory price) | 197 | 163 |
Spain (ex-factory price) | 173 | 159 |
Sweden (ex-factory price) | 283 | 208 |
Ukraine (ex-factory price) | 340 | 240 |
United Kingdom (pharmacist purchase price, 12.5% margin) | 177 | 159 |
United States | ||
US (wholesale acquisition cost) | 499 | 369 |
Rest of the world | ||
Australia (price to customer) | 490 | 340 |
Brazil (maximum price to consumer) | 797 | 765 |
Korea (medical insurance price) | 233 | 225 |
Russia (end-consumer price) | 475 | 370 |
Note: Costs were converted into Euros based on average exchange rates in May 2011.8